212 related articles for article (PubMed ID: 29393362)
21. The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG.
Lv C; Zeng HW; Wang JX; Yuan X; Zhang C; Fang T; Yang PM; Wu T; Zhou YD; Nagle DG; Zhang WD
Cell Death Dis; 2018 Feb; 9(2):165. PubMed ID: 29416003
[TBL] [Abstract][Full Text] [Related]
22. Lycopene Inhibits Activation of Epidermal Growth Factor Receptor and Expression of Cyclooxygenase-2 in Gastric Cancer Cells.
Han H; Lim JW; Kim H
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31491956
[TBL] [Abstract][Full Text] [Related]
23. Diterpenoid Tanshinones, the extract from Danshen (Radix Salviae Miltiorrhizae) induced apoptosis in nine human cancer cell lines.
Shen L; Lou Z; Zhang G; Xu G; Zhang G
J Tradit Chin Med; 2016 Aug; 36(4):514-21. PubMed ID: 28459519
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
Li X; Li Z; Li X; Liu B; Liu Z
BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential.
Chiu TL; Su CC
Int J Mol Med; 2010 Feb; 25(2):231-6. PubMed ID: 20043132
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone IIA regulates colorectal cancer apoptosis via attenuation of Parkin‑mediated mitophagy by suppressing AMPK/Skp2 pathways.
He L; Gu K
Mol Med Rep; 2018 Aug; 18(2):1692-1703. PubMed ID: 29845197
[TBL] [Abstract][Full Text] [Related]
27. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1α.
Kim JY; Song JJ; Kwon BM; Lee JD
Mol Med Rep; 2015 Sep; 12(3):4604-4609. PubMed ID: 26080622
[TBL] [Abstract][Full Text] [Related]
29. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells.
Su CC; Chen GW; Lin JG
Int J Mol Med; 2008 Nov; 22(5):613-8. PubMed ID: 18949381
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways.
Jieensinue S; Zhu H; Li G; Dong K; Liang M; Li Y
BMC Cell Biol; 2018 Sep; 19(1):21. PubMed ID: 30253740
[TBL] [Abstract][Full Text] [Related]
32. Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo.
Chien SY; Kuo SJ; Chen YL; Chen DR; Cheng CY; Su CC
Mol Med Rep; 2012 Jan; 5(1):282-6. PubMed ID: 22002472
[TBL] [Abstract][Full Text] [Related]
33. FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.
Li K; Guo Q; Yang J; Chen H; Hu K; Zhao J; Zheng S; Pang X; Zhou S; Dang Y; Li L
Oncotarget; 2017 Jan; 8(3):5048-5056. PubMed ID: 27926503
[TBL] [Abstract][Full Text] [Related]
34. Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.
Cerrito MG; Galbaugh T; Wang W; Chopp T; Salomon D; Cutler ML
J Cell Physiol; 2004 Nov; 201(2):244-58. PubMed ID: 15334659
[TBL] [Abstract][Full Text] [Related]
35. Pathway crosstalk between Ras/Raf and PI3K in promotion of M-CSF-induced MEK/ERK-mediated osteoclast survival.
Bradley EW; Ruan MM; Vrable A; Oursler MJ
J Cell Biochem; 2008 Jul; 104(4):1439-51. PubMed ID: 18275061
[TBL] [Abstract][Full Text] [Related]
36. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
37. Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer.
Lin Z; Zhang C; Zhang M; Xu D; Fang Y; Zhou Z; Chen X; Qin N; Zhang X
PLoS One; 2014; 9(1):e85296. PubMed ID: 24465527
[TBL] [Abstract][Full Text] [Related]
38. Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers.
Jing X; Xu Y; Cheng W; Guo S; Zou Y; He L
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1171-81. PubMed ID: 27100736
[TBL] [Abstract][Full Text] [Related]
39. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
40. Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.
Wang S; Zhang X; Wang G; Cao B; Yang H; Jin L; Cui M; Mao Y
BMC Cancer; 2019 Nov; 19(1):1160. PubMed ID: 31783811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
